AI assistant
TERADYNE, INC — Director's Dealing 2021
Mar 22, 2021
14837_dirs_2021-03-22_c851ac7c-5b9c-4343-b823-2394419146c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TERADYNE, INC (TER)
CIK: 0000097210
Period of Report: 2021-03-18
Reporting Person: JAGIELA MARK E (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-18 | Common Stock | M | 12183 | $36.75 | Acquired | 281413 | Direct |
| 2021-03-18 | Common Stock | M | 8644 | $47.7 | Acquired | 290057 | Direct |
| 2021-03-18 | Common Stock | M | 14026 | $28.56 | Acquired | 304083 | Direct |
| 2021-03-18 | Common Stock | M | 7861 | $72.1 | Acquired | 311944 | Direct |
| 2021-03-18 | Common Stock | S | 22169 | $112.81 | Disposed | 289775 | Direct |
| 2021-03-18 | Common Stock | S | 17921 | $114.03 | Disposed | 271854 | Direct |
| 2021-03-18 | Common Stock | S | 34199 | $114.96 | Disposed | 237655 | Direct |
| 2021-03-18 | Common Stock | S | 16256 | $115.68 | Disposed | 221399 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-18 | Stock Option (Right to Buy) | $36.75 | M | 12183 | Disposed | 2026-01-25 | Common Stock (12183) | Direct |
| 2021-03-18 | Stock Option (Right to Buy) | $47.70 | M | 8644 | Disposed | 2025-01-26 | Common Stock (8644) | Direct |
| 2021-03-18 | Stock Option (Right to Buy) | $28.56 | M | 14026 | Disposed | 2024-01-27 | Common Stock (14026) | Direct |
| 2021-03-18 | Stock Option (Right to Buy) | $72.1 | M | 7861 | Disposed | 2027-01-24 | Common Stock (7861) | Direct |
Footnotes
F1: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2: The option vests 25% per year over four years beginning on January 25, 2020, the first anniversary of the grant.
F3: The option vests 25% per year over four years beginning on January 26, 2019, the first anniversary of the grant.
F4: The option vests 25% per year over four years beginning on January 27, 2018, the first anniversary of the grant.
F5: The option vests 25% per year over four years beginning on January 24, 2021, the first anniversary of the grant.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.40 to $113.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.41 to $114.41. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.42 to $115.42. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.43 to $115.98. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.